Volker Vetter

803 total citations
24 papers, 523 citations indexed

About

Volker Vetter is a scholar working on Epidemiology, Infectious Diseases and Health. According to data from OpenAlex, Volker Vetter has authored 24 papers receiving a total of 523 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 9 papers in Infectious Diseases and 5 papers in Health. Recurrent topics in Volker Vetter's work include Viral gastroenteritis research and epidemiology (6 papers), Vaccine Coverage and Hesitancy (5 papers) and Virology and Viral Diseases (4 papers). Volker Vetter is often cited by papers focused on Viral gastroenteritis research and epidemiology (6 papers), Vaccine Coverage and Hesitancy (5 papers) and Virology and Viral Diseases (4 papers). Volker Vetter collaborates with scholars based in Belgium, Germany and Italy. Volker Vetter's co-authors include Marla Shapiro, Leonard R. Friedland, Bernd Benninghoff, Paolo Bonanni, Sven‐Arne Silfverdal, Ray Borrow, Marco Aurélio Palazzi Sáfadi, Roger Baxter, Andrew Vyse and T. Mark Doherty and has published in prestigious journals such as The Journal of Pediatrics, Vaccine and Acta Paediatrica.

In The Last Decade

Volker Vetter

22 papers receiving 504 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Volker Vetter Belgium 12 204 195 108 106 91 24 523
Stephanie Jones South Africa 14 499 2.4× 218 1.1× 94 0.9× 169 1.6× 96 1.1× 23 779
Hannah M. Cheeseman United Kingdom 12 187 0.9× 236 1.2× 99 0.9× 50 0.5× 269 3.0× 18 619
Steve Black United States 14 313 1.5× 216 1.1× 78 0.7× 129 1.2× 44 0.5× 27 749
Wayne Dimech Australia 18 331 1.6× 159 0.8× 91 0.8× 36 0.3× 100 1.1× 54 754
Tessa Braeckman Belgium 13 212 1.0× 323 1.7× 73 0.7× 179 1.7× 116 1.3× 21 661
Zsófia Mészner Hungary 13 275 1.3× 143 0.7× 70 0.6× 61 0.6× 23 0.3× 40 458
Preeyaporn Vichaiwattana Thailand 19 477 2.3× 524 2.7× 46 0.4× 146 1.4× 70 0.8× 69 971
Daniel Desgrandchamps Switzerland 12 403 2.0× 167 0.9× 49 0.5× 114 1.1× 60 0.7× 25 645
Gaby Smits Netherlands 18 522 2.6× 279 1.4× 76 0.7× 269 2.5× 212 2.3× 38 860
María Garcés‐Sánchez Spain 14 625 3.1× 179 0.9× 222 2.1× 140 1.3× 47 0.5× 66 756

Countries citing papers authored by Volker Vetter

Since Specialization
Citations

This map shows the geographic impact of Volker Vetter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Volker Vetter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Volker Vetter more than expected).

Fields of papers citing papers by Volker Vetter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Volker Vetter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Volker Vetter. The network helps show where Volker Vetter may publish in the future.

Co-authorship network of co-authors of Volker Vetter

This figure shows the co-authorship network connecting the top 25 collaborators of Volker Vetter. A scholar is included among the top collaborators of Volker Vetter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Volker Vetter. Volker Vetter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Casabona, G., et al.. (2025). Breaking the cycle: considerations for a life-course vaccination strategy against varicella-zoster virus. Expert Review of Vaccines. 24(1). 556–569.
2.
Buti, Marı́a, Paolo Bonanni, Nimzing G. Ladep, et al.. (2025). Toward elimination of hepatitis A and B in Europe: vaccination successes, challenges, and opportunities. Expert Review of Vaccines. 24(1). 373–383.
3.
Doherty, T. Mark, et al.. (2023). Response letter Re: The burden of seasonal influenza: improving vaccination coverage to mitigate morbidity and its impact on healthcare systems. Expert Review of Vaccines. 22(1). 528–529. 1 indexed citations
4.
Doherty, T. Mark, et al.. (2022). Lifting non-pharmaceutical interventions following the COVID-19 pandemic – the quiet before the storm?. Expert Review of Vaccines. 21(11). 1541–1553. 28 indexed citations
5.
Izurieta, Patricia, et al.. (2022). Systematic review of the efficacy, effectiveness and impact of high-valency pneumococcal conjugate vaccines on otitis media. Human Vaccines & Immunotherapeutics. 18(1). 2013693–2013693. 9 indexed citations
6.
Vetter, Volker, et al.. (2021). Established and new rotavirus vaccines: a comprehensive review for healthcare professionals. Human Vaccines & Immunotherapeutics. 18(1). 1870395–1870395. 15 indexed citations
7.
Heffernan, Catherine, et al.. (2021). Measles, mumps, rubella prevention: how can we do better?. Expert Review of Vaccines. 20(7). 811–826. 22 indexed citations
8.
Vetter, Volker, et al.. (2020). Fifteen years of experience with the oral live-attenuated human rotavirus vaccine: reflections on lessons learned. Expert Review of Vaccines. 19(8). 755–769. 11 indexed citations
9.
Vetter, Volker, et al.. (2020). Rotavirus vaccination and intussusception: a paradigm shift?. Human Vaccines & Immunotherapeutics. 17(1). 278–282. 6 indexed citations
10.
Benninghoff, Bernd, et al.. (2019). Role of healthcare practitioners in rotavirus disease awareness and vaccination – insights from a survey among caregivers. Human Vaccines & Immunotherapeutics. 16(1). 138–147. 11 indexed citations
12.
Willame, Corinne, Ouzama Henry, Lan Lin, et al.. (2017). Pain caused by measles, mumps, and rubella vaccines: A systematic literature review. Vaccine. 35(42). 5551–5558. 2 indexed citations
13.
Vetter, Volker, et al.. (2017). Understanding modern-day vaccines: what you need to know. Annals of Medicine. 50(2). 110–120. 227 indexed citations
14.
Vetter, Volker, Roger Baxter, Marco Aurélio Palazzi Sáfadi, et al.. (2015). Routinely vaccinating adolescents against meningococcus: targeting transmission & disease. Expert Review of Vaccines. 15(5). 641–658. 55 indexed citations
17.
Knuf, Markus, Fred Zepp, Claudius U. Meyer, et al.. (2010). Safety, immunogenicity and immediate pain of intramuscular versus subcutaneous administration of a measles–mumps–rubella–varicella vaccine to children aged 11–21 months. European Journal of Pediatrics. 169(8). 925–933. 27 indexed citations
18.
Zenker, Martin, et al.. (2000). Paravertebral and intraspinal malposition of transfemoral central venous catheters in newborns. The Journal of Pediatrics. 136(6). 837–840. 6 indexed citations
19.
Zenker, Martin, M. Ries, Volker Vetter, R. Rauch, & D. Harms. (1999). Non‐catheter‐related aortic thrombosis and resistance to activated protein C in a premature newborn. Acta Paediatrica. 88(9). 1035–1038. 2 indexed citations
20.
Vetter, Volker, et al.. (1995). Case of the month. European Journal of Pediatrics. 154(11). 935–936. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026